Literature DB >> 30258532

GPR40 Receptor Agonists for the Treatment of Type 2 Diabetes and Related Diseases.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2018        PMID： 30258532      PMCID： PMC6142065          DOI： 10.1021/acsmedchemlett.8b00343

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  4 in total

Review 1.  GPR40 agonists for the treatment of type 2 diabetes mellitus: The biological characteristics and the chemical space.

Authors:  Cheng Chen; He Li; Ya-Qiu Long
Journal:  Bioorg Med Chem Lett       Date:  2016-10-26       Impact factor: 2.823

Review 2.  Structural basis for the agonist action at free fatty acid receptor 1 (FFA1R or GPR40).

Authors:  Daniel Alencar Rodrigues; Pedro de Sena Murteira Pinheiro; Thayssa Tavares da Silva Cunha Ferreira; Sreekanth Thota; Carlos Alberto Manssour Fraga
Journal:  Chem Biol Drug Des       Date:  2017-11-16       Impact factor: 2.817

Review 3.  β-Cell signalling and insulin secretagogues: A path for improved diabetes therapy.

Authors:  Susumu Seino; Kenji Sugawara; Norihide Yokoi; Harumi Takahashi
Journal:  Diabetes Obes Metab       Date:  2017-09       Impact factor: 6.577

Review 4.  GPR40 Agonists for the Treatment of Type 2 Diabetes Mellitus: Benefits and Challenges.

Authors:  Sameer Mohammad
Journal:  Curr Drug Targets       Date:  2016       Impact factor: 2.937
  4 in total
  3 in total

1.  Metabolism of fatty acids and bile acids in plasma is associated with overactive bladder in males: potential biomarkers and targets for novel treatments in a metabolomics analysis.

Authors:  Takahiko Mitsui; Satoru Kira; Tatsuya Ihara; Norifumi Sawada; Hiroshi Nakagomi; Tatsuya Miyamoto; Hiroshi Shimura; Sachiko Tsuchiya; Mie Kanda; Masayuki Takeda
Journal:  Int Urol Nephrol       Date:  2019-10-05       Impact factor: 2.370

Review 2.  Metabolite G-Protein Coupled Receptors in Cardio-Metabolic Diseases.

Authors:  Derek Strassheim; Timothy Sullivan; David C Irwin; Evgenia Gerasimovskaya; Tim Lahm; Dwight J Klemm; Edward C Dempsey; Kurt R Stenmark; Vijaya Karoor
Journal:  Cells       Date:  2021-11-29       Impact factor: 7.666

3.  Pharmacophore-guided repurposing of fibrates and retinoids as GPR40 allosteric ligands with activity on insulin release.

Authors:  Erika Cione; Maria Cristina Caroleo; Hiroyuki Kagechika; Fabrizio Manetti
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.